Wedbush Starts AVI BioPharma (AVII) at Outperform; Advancing Nucleotide Drugs Targeting Molecular Machinery of Translation

Go back to Wedbush Starts AVI BioPharma (AVII) at Outperform; Advancing Nucleotide Drugs Targeting Molecular Machinery of Translation
AVI BioPharma, Inc. (NASDAQ: AVII) Delayed: 0.66 --0 (-0%)
Previous Close $0.66    52 Week High $1.68 
Open $71.89    52 Week Low $0.43 
Day High $0.66    P/E N/A 
Day Low $0.66    EPS $-0.16 
Volume 38,332